Jose Delagandara
West Palm Beach, FLNPI 1265432041
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $766 of the $1,262 with a category attached, or 60.7%. 5 manufacturers reported payments, led by Grifols Biologicals LLC at 44.6% of the total. Reporting peaked in 2019 at $1,022 and has fallen 87.8% since, to $125 in 2023.
Across 10 payments — averaging $126.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols Biologicals LLC$563
- Eisai Inc.$367
- Otsuka America Pharmaceutical, Inc.$125
- Livanova USA, Inc.$116
- Genentech USA, Inc.$92
Across 320 payments — averaging $14,066 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$2.4M
- Biogen$859K
- Eli Lilly$539K
- Grifols Biologicals LLC$241K
- E.r. Squibb & Sons, L.L.C.$182K
- Avanir Pharmaceuticals, Inc.$109K
- plus $194K from 7 others
What the payments were for
- Travel & lodging$76661%
- Food & beverage$49639%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols Biologicals LLC | 2 | $563 |
| Eisai Inc. | 5 | $367 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Livanova USA, Inc. | 1 | $116 |
| Genentech USA, Inc. | 1 | $92 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Albutein$563
- Flebogamma DIF$563
- REXULTI$125
- VNS Therapy$116
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 12 | $98 |
| Clonazepam | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.